{"database": "lobbying", "table": "lobbying_activities", "rows": [[2777687, "6b071f1c-f9ea-4637-aa9a-b314d51e7279", "Q1", "MARSHALL & POPP, LLC", 401105121, "AMGEN USA INC.", 2022, "first_quarter", "CPT", "Issues related to intellectual property and patent reform, including S.1435, the Affordable Prescriptions for Patients Act and H.R. 4521/S.1260, the United States Innovation and Competition Act.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2022-04-18T06:41:42-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2777687"], "units": {}, "query_ms": 0.5118219996802509, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}